Stock News

Adamas Pharmaceuticals (Put) (ADMS) Shareholder Pura Vida Investments Has Boosted Holding; As Microsoft (MSFT) Shares Rose, Smith Chas P & Associates Pa Cpas Has Boosted Stake

Pura Vida Investments Llc increased its stake in Adamas Pharmaceuticals Inc (Put) (ADMS) by 89.63% based on its latest 2017Q3 regulatory filing with the SEC. Pura Vida Investments Llc bought 70,897 shares as the company’s stock declined 13.31% while stock markets rallied. The institutional investor held 150,000 shares of the health care company at the end of 2017Q3, valued at $97.50M, up from 79,103 at the end of the previous reported quarter. Pura Vida Investments Llc who had been investing in Adamas Pharmaceuticals Inc (Put) for a number of months, seems to be bullish on the $810.47 million market cap company. The stock decreased 0.08% or $0.03 during the last trading session, reaching $35.58. About 424,802 shares traded. Adamas Pharmaceuticals, Inc. (NASDAQ:ADMS) has declined 0.40% since January 16, 2017 and is downtrending. It has underperformed by 17.10% the S&P500.

Smith Chas P & Associates Pa Cpas increased its stake in Microsoft (MSFT) by 7.63% based on its latest 2017Q3 regulatory filing with the SEC. Smith Chas P & Associates Pa Cpas bought 14,788 shares as the company’s stock rose 4.75% with the market. The institutional investor held 208,557 shares of the prepackaged software company at the end of 2017Q3, valued at $15.54 million, up from 193,769 at the end of the previous reported quarter. Smith Chas P & Associates Pa Cpas who had been investing in Microsoft for a number of months, seems to be bullish on the $691.23 billion market cap company. The stock increased 1.73% or $1.52 during the last trading session, reaching $89.6. About 24.27M shares traded or 8.63% up from the average. Microsoft Corporation (NASDAQ:MSFT) has risen 34.52% since January 16, 2017 and is uptrending. It has outperformed by 17.82% the S&P500.

Among 11 analysts covering Adamas Pharmaceuticals (NASDAQ:ADMS), 10 have Buy rating, 1 Sell and 0 Hold. Therefore 91% are positive. Adamas Pharmaceuticals had 26 analyst reports since August 7, 2015 according to SRatingsIntel. Mizuho maintained it with “Buy” rating and $48.0 target in Friday, November 3 report. Northland Capital initiated Adamas Pharmaceuticals, Inc. (NASDAQ:ADMS) rating on Wednesday, November 29. Northland Capital has “Buy” rating and $70.0 target. Noble Financial initiated the shares of ADMS in report on Friday, June 17 with “Buy” rating. The firm has “Outperform” rating given on Thursday, December 24 by Credit Suisse. On Tuesday, September 22 the stock rating was initiated by Aegis Capital with “Buy”. Needham maintained the stock with “Buy” rating in Friday, September 15 report. The rating was initiated by JMP Securities with “Market Outperform” on Friday, April 1. The firm earned “Buy” rating on Wednesday, August 9 by Noble Financial. Piper Jaffray maintained Adamas Pharmaceuticals, Inc. (NASDAQ:ADMS) rating on Tuesday, August 8. Piper Jaffray has “Buy” rating and $2200 target. Zacks downgraded Adamas Pharmaceuticals, Inc. (NASDAQ:ADMS) on Friday, August 7 to “Buy” rating.

Pura Vida Investments Llc, which manages about $223.00M and $199.58 billion US Long portfolio, decreased its stake in Envision Healthcare Corp by 64,008 shares to 123,192 shares, valued at $5.54 billion in 2017Q3, according to the filing. It also reduced its holding in Synergy Pharmaceuticals Del (Call) (NASDAQ:SGYP) by 167,800 shares in the quarter, leaving it with 100,000 shares, and cut its stake in Nanostring Technologies Inc (NASDAQ:NSTG).

Investors sentiment increased to 0.83 in 2017 Q3. Its up 0.01, from 0.82 in 2017Q2. It is positive, as 40 investors sold MSFT shares while 952 reduced holdings. 114 funds opened positions while 708 raised stakes. 5.51 billion shares or 0.32% less from 5.53 billion shares in 2017Q2 were reported. Fisher Asset Management Limited Liability Corporation owns 1.72% invested in Microsoft Corporation (NASDAQ:MSFT) for 16.44 million shares. Harris Assocs Limited Partnership has 0.31% invested in Microsoft Corporation (NASDAQ:MSFT). Hs Mngmt Ptnrs Limited Liability Com holds 8.19% of its portfolio in Microsoft Corporation (NASDAQ:MSFT) for 3.40M shares. Woodmont Invest Counsel Ltd Llc accumulated 1.52% or 74,813 shares. Sterling Cap Mgmt Llc has invested 0.98% in Microsoft Corporation (NASDAQ:MSFT). Loomis Sayles And LP reported 11.84M shares stake. Barton Inv Management reported 27,946 shares. Nbw Cap Ltd Liability Corporation reported 2.4% in Microsoft Corporation (NASDAQ:MSFT). Midwest Inv Mgmt Ltd Limited Liability Company, Ohio-based fund reported 3,000 shares. Moreover, Nikko Asset Mgmt Americas has 0.28% invested in Microsoft Corporation (NASDAQ:MSFT) for 77,000 shares. Focused Wealth Mngmt Inc has invested 0.18% in Microsoft Corporation (NASDAQ:MSFT). Mogy Joel R Invest Counsel reported 4.28% in Microsoft Corporation (NASDAQ:MSFT). Oakbrook Limited Liability invested in 377,232 shares or 1.81% of the stock. Old Mutual Glob Investors (Uk) Ltd reported 665,387 shares. Moors Cabot accumulated 1.47% or 136,915 shares.

Smith Chas P & Associates Pa Cpas, which manages about $915.98 million and $700.44M US Long portfolio, decreased its stake in Johnson & Johnson (NYSE:JNJ) by 2,842 shares to 178,622 shares, valued at $23.22M in 2017Q3, according to the filing. It also reduced its holding in Kinder Morgan Inc Com (NYSE:KMI) by 25,550 shares in the quarter, leaving it with 219,711 shares, and cut its stake in Abbott Laboratories (NYSE:ABT).

Since August 4, 2017, it had 0 insider purchases, and 3 selling transactions for $513.86 million activity. On Friday, August 4 the insider Morfit G Mason sold $507.89 million. 55,000 shares were sold by Hood Amy, worth $4.00M.

Among 35 analysts covering Microsoft Corporation (NASDAQ:MSFT), 29 have Buy rating, 2 Sell and 4 Hold. Therefore 83% are positive. Microsoft Corporation had 143 analyst reports since July 22, 2015 according to SRatingsIntel. The rating was maintained by FBR Capital with “Outperform” on Friday, October 23. The firm has “Sell” rating given on Monday, September 25 by Jefferies. The firm has “Buy” rating by Credit Suisse given on Tuesday, August 22. Wunderlich upgraded Microsoft Corporation (NASDAQ:MSFT) rating on Friday, October 21. Wunderlich has “Buy” rating and $70 target. The firm earned “Buy” rating on Friday, October 27 by Canaccord Genuity. Cowen & Co upgraded the shares of MSFT in report on Tuesday, May 24 to “Outperform” rating. The firm earned “Sell” rating on Friday, October 27 by Citigroup. The rating was maintained by BMO Capital Markets on Friday, October 21 with “Outperform”. The company was maintained on Friday, July 21 by Deutsche Bank. Oppenheimer maintained it with “Outperform” rating and $92 target in Tuesday, October 31 report.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.


Leave a Reply

Your email address will not be published. Required fields are marked *